| scholarly article | Q13442814 |
| P50 | author | Henrique J Cardoso | Q59675157 |
| Marília I Figueira | Q59675160 | ||
| Sílvia Socorro | Q38589960 | ||
| P2093 | author name string | Henrique J Cardoso | |
| Marília I Figueira | |||
| P2860 | cites work | Signaling through extracellular signal-regulated kinase is required for spermatogonial proliferative response to stem cell factor | Q61191165 |
| Stem cell factor-induced signal transduction in rat mast cells. Activation of phospholipase D but not phosphoinositide-specific phospholipase C in c-kit receptor stimulation | Q72086709 | ||
| Differential stimulation of c-Kit mutants by membrane-bound and soluble Steel Factor correlates with leukemic potential | Q73219883 | ||
| Expression of proto-oncogene c-kit in high risk prostate cancer | Q80894250 | ||
| KIT (c-kit oncogene product) pathway is constitutively activated in human testicular germ cell tumors | Q81270275 | ||
| Identification of Tyr-703 and Tyr-936 as the primary association sites for Grb2 and Grb7 in the c-Kit/stem cell factor receptor | Q22010151 | ||
| Lyn is required for normal stem cell factor-induced proliferation and chemotaxis of primary hematopoietic cells | Q24291395 | ||
| Stat1 associates with c-kit and is activated in response to stem cell factor | Q24530497 | ||
| Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand | Q24555963 | ||
| Cell signaling by receptor tyrosine kinases | Q24598357 | ||
| Testicular cancer: a prototypic tumor of young adults | Q24655649 | ||
| Crystal structure of human stem cell factor: implication for stem cell factor receptor dimerization and activation | Q27625275 | ||
| Structure of a c-kit product complex reveals the basis for kinase transactivation | Q27641501 | ||
| New Progress of Epigenetic Biomarkers in Urological Cancer | Q28073982 | ||
| Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers | Q28082793 | ||
| The protein tyrosine kinase family of the human genome | Q28140214 | ||
| Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells | Q28183216 | ||
| Oncogenic kinase signalling | Q28189493 | ||
| Control of stem cell self-renewal in Drosophila spermatogenesis by JAK-STAT signaling | Q28213000 | ||
| Lyn associates with the juxtamembrane region of c-Kit and is activated by stem cell factor in hematopoietic cell lines and normal progenitor cells | Q28252234 | ||
| The kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akt-mediated phosphorylation of Bad on Ser136 | Q28275577 | ||
| Stem cell factor receptor/c-Kit: from basic science to clinical implications | Q28277237 | ||
| Tyrosine residue 719 of the c-kit receptor is essential for binding of the P85 subunit of phosphatidylinositol (PI) 3-kinase and for c-kit-associated PI 3-kinase activity in COS-1 cells | Q28285759 | ||
| Signal transduction via the stem cell factor receptor/c-Kit | Q28291675 | ||
| Generation of a prostate from a single adult stem cell | Q28298344 | ||
| Direct association of Csk homologous kinase (CHK) with the diphosphorylated site Tyr568/570 of the activated c-KIT in megakaryocytes | Q28303950 | ||
| Stem cell factor/c-kit signaling mediated cardiac stem cell migration via activation of p38 MAPK | Q28569847 | ||
| Dissection of the c-Kit signaling pathway in mouse primordial germ cells by retroviral-mediated gene transfer | Q28593279 | ||
| JAK2 is associated with the c-kit proto-oncogene product and is phosphorylated in response to stem cell factor | Q28637652 | ||
| Kit receptor dimerization is driven by bivalent binding of stem cell factor | Q28637863 | ||
| MAP kinase signalling pathways in cancer | Q29615542 | ||
| Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012 | Q29615661 | ||
| Tr-kit promotes the formation of a multimolecular complex composed by Fyn, PLCgamma1 and Sam68. | Q30164372 | ||
| Requirement of Gab2 for mast cell development and KitL/c-Kit signaling | Q30167578 | ||
| Involvement of phospholipase Cgamma1 in mouse egg activation induced by a truncated form of the C-kit tyrosine kinase present in spermatozoa. | Q30176067 | ||
| Epidemiology of Prostate and Testicular Cancer | Q30248216 | ||
| Activating c-kit gene mutations in human germ cell tumors | Q30304054 | ||
| Mechanisms of activation of receptor tyrosine kinases: monomers or dimers | Q33883884 | ||
| Tr-kit-induced resumption of the cell cycle in mouse eggs requires activation of a Src-like kinase | Q34150271 | ||
| Epigenetic susceptibility factors for prostate cancer with aging. | Q34541756 | ||
| KIT mutations are common in testicular seminomas | Q35083255 | ||
| Of JAKs, STATs, blind watchmakers, jeeps and trains | Q35163904 | ||
| Involvement of Fyn kinase in Kit and integrin-mediated Rac activation, cytoskeletal reorganization, and chemotaxis of mast cells. | Q35804427 | ||
| Human Stromal Cells in the Peripheral Zone of the Prostate Promote Tumorigenesis of Prostatic Cancer Stem Cells through Up-regulation of C-Kit Expression | Q35856865 | ||
| STI571 reduces TRAIL-induced apoptosis in colon cancer cells: c-Abl activation by the death receptor leads to stress kinase-dependent cell death. | Q35946035 | ||
| Phase I study investigating the safety and feasibility of combining imatinib mesylate (Gleevec) with sorafenib in patients with refractory castration-resistant prostate cancer | Q36166836 | ||
| Somatic mutations of KIT in familial testicular germ cell tumours | Q36697196 | ||
| Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions. | Q36739411 | ||
| The interaction of small domains between the subunits of phosphatidylinositol 3-kinase determines enzyme activity | Q36745695 | ||
| Role of c-kit/SCF in cause and treatment of gastrointestinal stromal tumors (GIST). | Q36894901 | ||
| Somatic KIT mutations occur predominantly in seminoma germ cell tumors and are not predictive of bilateral disease: report of 220 tumors and review of literature | Q36974533 | ||
| Differential roles of PI3-kinase and Kit tyrosine 821 in Kit receptor-mediated proliferation, survival and cell adhesion in mast cells. | Q37693932 | ||
| Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance. | Q37977174 | ||
| Extracellular assembly and activation principles of oncogenic class III receptor tyrosine kinases | Q38053052 | ||
| Therapeutic targeting of c-KIT in cancer | Q38057806 | ||
| miRNA and TMPRSS2-ERG do not mind their own business in prostate cancer cells | Q38096240 | ||
| Recent advances in molecular and cell biology of testicular germ-cell tumors. | Q38254896 | ||
| The SCF/c-KIT system in the male: Survival strategies in fertility and cancer | Q38264052 | ||
| Hormonal regulation of c-KIT receptor and its ligand: implications for human infertility? | Q38275897 | ||
| Stem cell factor activates STAT-5 DNA binding in IL-3-derived bone marrow mast cells | Q38347182 | ||
| Overview on the complexity of androgen receptor-targeted therapy for prostate cancer | Q38364166 | ||
| Signaling lansdscape of prostate cancer | Q38717542 | ||
| Prostate Cancer Stem Cells: Viewing Signaling Cascades at a Finer Resolution | Q38723375 | ||
| Expression of a truncated form of the c-Kit tyrosine kinase receptor and activation of Src kinase in human prostatic cancer | Q38730400 | ||
| Paradoxical and contradictory effects of imatinib in two cell line models of hormone-refractory prostate cancer | Q38897955 | ||
| Differential activity of c-KIT splice forms is controlled by extracellular peptide insert length. | Q39121231 | ||
| Secondary c-Kit mutations confer acquired resistance to RTK inhibitors in c-Kit mutant melanoma cells. | Q39167351 | ||
| Regulation of cell proliferation through a KIT-mediated mechanism in benign prostatic hyperplasia. | Q39400004 | ||
| Schedule treatment design and quantitative in vitro evaluation of chemotherapeutic combinations for metastatic prostate cancer therapy. | Q39716863 | ||
| Expression of c-Kit isoforms in multiple myeloma: differences in signaling and drug sensitivity. | Q39987410 | ||
| Activation of the MAP kinase pathway by c-Kit is PI-3 kinase dependent in hematopoietic progenitor/stem cell lines | Q40583274 | ||
| Src family kinases are involved in the differential signaling from two splice forms of c-Kit | Q40679645 | ||
| Kit signaling inhibits the sphingomyelin-ceramide pathway through PLC gamma 1: implication in stem cell factor radioprotective effect. | Q40714444 | ||
| Role of p38 and ERK MAP kinase in proliferation of erythroid progenitors in response to stimulation by soluble and membrane isoforms of stem cell factor. | Q40714451 | ||
| Gastric GISTs: Analysis of c-Kit, PDGFRA and BRAF mutations in relation to prognosis and clinical pathological characteristics of patients - A GIRCG study. | Q40717804 | ||
| Soluble Kit receptor blocks stem cell factor bioactivity in vitro | Q40812961 | ||
| Lyn is activated during late G1 of stem-cell-factor-induced cell cycle progression in haemopoietic cells | Q40938029 | ||
| A point mutation in the catalytic domain of c-kit induces growth factor independence, tumorigenicity, and differentiation of mast cells. | Q41206096 | ||
| Membrane-bound Steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form. | Q41378313 | ||
| Stem cell factor, the JAK-STAT pathway and signal transduction | Q41708996 | ||
| Identification of a ligand for the c-kit proto-oncogene | Q41718674 | ||
| Label retention and stem cell marker expression in the developing and adult prostate identifies basal and luminal epithelial stem cell subpopulations | Q42112184 | ||
| Differential expression of the c-kit proto-oncogene in germ cell tumours. | Q42513650 | ||
| A novel c-kit transcript, potentially encoding a truncated receptor, originates within a kit gene intron in mouse spermatids. | Q42602776 | ||
| Isoforms of c-KIT differ in activation of signalling pathways and transformation of NIH3T3 fibroblasts | Q42809755 | ||
| Phase I trial of zoledronic acid + imatinib mesylate (Gleevec) in patients with bone metastases | Q43299092 | ||
| Stem cell factor/c-kit up-regulates cyclin D3 and promotes cell cycle progression via the phosphoinositide 3-kinase/p70 S6 kinase pathway in spermatogonia | Q43503981 | ||
| Dimerization of Kit-ligand and efficient cell-surface presentation requires a conserved Ser-Gly-Gly-Tyr motif in its transmembrane domain | Q43840377 | ||
| Selective loss of gastrointestinal mast cells and impaired immunity in PI3K-deficient mice | Q43933405 | ||
| Alterations of the c-kit gene in testicular germ cell tumors | Q44490297 | ||
| Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer | Q44889720 | ||
| Platelet-derived growth factor receptor inhibitor imatinib mesylate and docetaxel: a modular phase I trial in androgen-independent prostate cancer | Q45018087 | ||
| Ectopic expression of KitD814Y in spermatids of transgenic mice, interferes with sperm morphogenesis | Q45286586 | ||
| Expression of stem cell factor and its receptor c-Kit during the development of intrahepatic cholangiocarcinoma. | Q45874538 | ||
| Properties of variant forms of human stem cell factor recombinantly expressed in Escherichia coli | Q46308495 | ||
| Combined low-dose imatinib mesylate and paclitaxel lack synergy in an experimental model of extra-osseous hormone-refractory prostate cancer | Q46654052 | ||
| Complete response after treatment with imatinib in pretreated disseminated testicular seminoma with overexpression of c-KIT. | Q46919489 | ||
| The evolving landscape of prostate cancer stem cell: Therapeutic implications and future challenges. | Q50889968 | ||
| A variant c-KIT mutation, D816H, fundamental to the sequential development of an ovarian mixed germ cell tumor and systemic mastocytosis with chronic myelomonocytic leukemia. | Q51363110 | ||
| Chemoattractant action and molecular signaling pathways of Kit ligand on mouse primordial germ cells. | Q51987573 | ||
| Detection of c-kit exons 11- and 17-activating mutations in testicular seminomas by high-resolution melting amplicon analysis. | Q54598705 | ||
| c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma | Q58194329 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 297-307 | |
| P577 | publication date | 2017-06-27 | |
| P1433 | published in | Journal of Cell Communication and Signaling | Q26841964 |
| P1476 | title | The stem cell factor (SCF)/c-KIT signalling in testis and prostate cancer | |
| P478 | volume | 11 |
| Q92447986 | Association between Circulation Indole-3-Acetic Acid Levels and Stem Cell Factor in Maintenance Hemodialysis Patients: A Cross-Sectional Study |
| Q53703721 | CD117/c-kit in Cancer Stem Cell-Mediated Progression and Therapeutic Resistance. |
| Q49610684 | Exploring the molecular aspects associated with testicular germ cell tumors: a review |
| Q58608388 | Prognostic and Clinic-Pathological Significances of SCF and COX-2 Expression in Inflammatory and Malignant Prostatic Lesions |
| Q64092289 | and evaluation of possible pro-survival activities of PGE2, EGF, TPO and FLT3L on human hematopoiesis |
Search more.